Andreas Hochhaus: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia American Society of Hematology 5:37 3 years ago 1 199 Скачать Далее
ASCEMBL: Asciminib for hard-to-treat chronic myeloid leukaemia ecancer 6:40 3 years ago 732 Скачать Далее
ASCEMBL: asciminib versus bosutinib in third-line treatment of CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 2:27 5 months ago 122 Скачать Далее
The BYOND trial: bosutinib shows promise in heavily pre-treated CML patients VJHemOnc – Video Journal of Hematology & HemOnc 2:04 3 years ago 229 Скачать Далее
Asciminib and bosutinib efficacy in CML-CP patients: a comparison study VJHemOnc – Video Journal of Hematology & HemOnc 3:28 3 years ago 494 Скачать Далее
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 153 Скачать Далее
Targeting TKI-resistant CML with LY3009120 and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 2:40 2 years ago 362 Скачать Далее
Five-year follow-up data from the BFORE trial: bosutinib versus imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:54 1 year ago 221 Скачать Далее
Final results of the BFORE trial: bosutinib vs imatinib in CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 300 Скачать Далее
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 346 Скачать Далее
Asciminib has the potential to succeed where other TKIs have failed in CML VJHemOnc – Video Journal of Hematology & HemOnc 0:58 5 years ago 505 Скачать Далее
iCMLf Conversation: Treatment of CML patients after failure of 2 TKIs International CML Foundation 46:54 1 year ago 77 Скачать Далее
Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid le... ecancer 4:36 2 years ago 542 Скачать Далее
iCMLf Conversation: CML Highlights of EHA 2023; Clinical and Biological Overview International CML Foundation 52:49 11 months ago 348 Скачать Далее
ASC2ESCALATE: dose escalation study of asciminib in second-line CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:35 1 year ago 104 Скачать Далее
ESH 2nd How to Diagnose and Treat CML / MPN: virtual tour of the platform ESH 1:55 3 years ago 182 Скачать Далее
Asciminib plus traditonal TKIs for chronic phase CML VJHemOnc – Video Journal of Hematology & HemOnc 3:08 5 years ago 615 Скачать Далее
Ongoing studies in CML: investigating asciminib toxicity and improving TFR rates VJHemOnc – Video Journal of Hematology & HemOnc 1:24 1 year ago 258 Скачать Далее
FDA Approves Use of Asciminib for Philadelphia Chromosome Positive Chronic Myeloid Leukaemia MedSynapse 3:45 2 years ago 323 Скачать Далее